Macmillan Cancer Support responds to cancer drugs fund announcement
Today [Thursday 28th August] the Government has announced an additional funding of £80 million pounds to the Cancer Drugs Fund. Responding to the announcement, Mike Hobday, Director of Policy and Research at Macmillan Cancer Support, says:
“We are very pleased that the Government has committed to an additional funding of £80 million for the Cancer Drugs Fund, and that it has committed to review the effectiveness of the current drugs on the list.
“Since its introduction, the fund has helped tens of thousands of patients access the vital drugs needed to treat or control their cancer. This new funding will mean that many more can be helped and that we can be confident that valuable NHS money will be targeted on the most effective treatments.
“Macmillan Cancer Support looks forward to working with the Government to continue to examine, and to improve, the wider cancer drugs approval process so that as many cancer patients as possible can access life-extending treatment. This is a key step in helping the Government reach its ambition to have the best cancer survival rates in Europe.”
